Home > Healthcare > Medical Devices > Diagnostic Devices > Vascular Imaging Market

Vascular Imaging Market Analysis

  • Report ID: GMI9106
  • Published Date: Apr 2024
  • Report Format: PDF

Vascular Imaging Market Analysis

Based on modality, the market is divided into computed tomography, MRI, ultrasound, nuclear medicine, and X-ray. The nuclear medicine segment is estimated to account for USD 3.6 billion by 2032.

 

  • Nuclear medicine techniques provide functional information about vascular physiology and metabolism complementing anatomical imaging modalities. By utilizing radiotracers that target specific physiological processes such as blood flow, tissue perfusion, and cellular metabolism, nuclear imaging offers valuable insights into vascular function.

     

  • These techniques are highly sensitive allowing for the detection of subtle vascular abnormalities and early-stage disease. This sensitivity is particularly beneficial for diagnosing conditions such as vasculitis, thromboembolism, and microvascular diseases.

     

  • Additionally, nuclear medicine including therapeutic nuclear medicine, enables quantitative analysis of vascular parameters such as blood flow, blood volume, and vascular permeability. This quantitative information plays a crucial role in disease characterization, treatment planning, and monitoring of therapeutic responses, allowing healthcare professionals to tailor interventions effectively and optimize patient outcomes. Thus, stimulating the growth of the segment.

 

Vascular Imaging Market, By Application (2023)

Based on application, the vascular imaging market is bifurcated into diagnostic and therapeutic. The diagnostic segment was reached USD 3.5 billion in 2023.

 

  • Vascular imaging allows for the early detection of vascular diseases and abnormalities enabling timely intervention and management. Early detection can prevent disease progression, reduce complications, and improve patient outcomes.

     

  • Provides real-time guidance for interventional procedures aimed at treating vascular diseases. Techniques such as fluoroscopy, intravascular ultrasound (IVUS), and image-guided catheterization enable precise navigation and placement of devices during angioplasty, stenting, embolization, and other minimally invasive procedures.

     

  • Additionally, vascular imaging allows for the evaluation of treatment response and post-procedural outcomes. Monitoring changes in vascular morphology, blood flow parameters, and lesion characteristics over time helps assess the effectiveness of medical therapies, interventions, and surgical procedures.

     

  • Thus, such aforementioned factors are expected to augment the segmental growth.

     

Based on procedure, the vascular imaging market is divided into coronary angiography, peripheral angiography, neurovascular angiography, vascular ultrasound, microangiography, cerebral angiography, and other procedures. The coronary angiography segment is projected to surpass USD 2.5 billion by 2032.

 

  • Coronary angiography provides high-resolution images of the coronary arteries, allowing for detailed visualization of the vessel lumen and the presence of any abnormalities such as stenosis, occlusions, or aneurysms.

     

  • It is considered the gold standard for diagnosing coronary artery disease (CAD). It allows for precise localization and quantification of coronary artery stenoses helps in guiding treatment decisions such as coronary artery bypass grafting (CABG) or percutaneous coronary intervention (PCI).

     

  • Further, it serves as a valuable tool for guiding interventional procedures such as balloon angioplasty, stent placement, and atherectomy. It allows interventional cardiologists to precisely position catheters and devices within the coronary arteries and optimize treatment outcomes. Thus, propelling the growth of the segment.

     

Based on end-use, the vascular imaging market is classified into hospitals, diagnostic imaging centres, and other end-users. The hospital segment will cross USD 5.2 billion in 2032.

 

  • Hospitals equipped with vascular imaging capabilities can offer comprehensive diagnostic services to patients with various vascular conditions. This includes the ability to perform a wide range of imaging modalities such as ultrasound, computed tomography angiography (CTA), magnetic resonance angiography (MRA), and digital subtraction angiography (DSA), enabling thorough evaluation and diagnosis.

     

  • Vascular imaging allows for the timely diagnosis and treatment of vascular diseases and abnormalities. Hospitals can promptly assess patients presenting with symptoms suggestive of vascular conditions, facilitating rapid intervention and management to prevent disease progression and associated complications. Thus, all these aforementioned factors are expected to drive segmental growth.

 

North America Vascular Imaging Market, 2021 – 2032 (USD Billion)

North America vascular imaging market size exceeded USD 2.6 billion in 2023 and is predicted to witness substantial market growth.

 

  • North America has a relatively high prevalence of cancer and cardiac diseases. For instance, the Centers for Disease Control and Prevention (CDCP) reports that heart disease claims one life every 33 seconds in the U.S., with nearly 695,000 deaths attributed to heart disease in 2021, accounting for one out of every five deaths.

     

  • Germany's robust healthcare system boasts advanced medical facilities and equipment including cutting-edge vascular imaging technologies. Additionally, the country hosts prestigious research institutions and universities specializing in medical imaging, vascular biology, and cardiovascular research, driving innovation in the field of vascular imaging technologies.

     

  • The incidence of cancer and cardiac diseases has notably increased in the UK. For instance, according to the British Heart Foundation in 2024, approximately 7.6 million people in the UK are living with heart and circulatory diseases, with approximately 4 million being men and 3.6 million being women.

     

  • South Korea is home to renowned research institutions and universities with expertise in medical imaging, vascular biology, and cardiovascular research, fostering innovation in vascular imaging technologies.

     

  • Saudi Arabia attracts skilled healthcare professionals from around the world including radiologists and imaging specialists, contributes to the delivery and advancement of vascular imaging services. Thus, propelling the growth of the market.
Authors: Mariam Faizullabhoy, Gauri Wani

Frequently Asked Questions (FAQ) :

The market size of vascular imaging was surpassed USD 6.4 billion in 2023 and could witness 5.9% CAGR between 2024 and 2032, owing to growing prevalence of cardiovascular diseases, rising elderly population and advancements in medical imaging technologies.

The diagnostic application segment in the vascular imaging industry will crossed USD 3.5 billion in 2023, primarily due to the crucial role played by diagnostic imaging in accurately assessing vascular health and identifying abnormalities.

North America vascular imaging market valuation crossed USD 2.6 billion in 2023, driven by high prevalence of cardiovascular diseases, coupled with the presence of advanced healthcare infrastructure, robust R&D activities, and favorable reimbursement policies.

Some of the leading vascular imaging industry players include Abbott Laboratories, GE HealthCare Technologies Inc., Hitachi, Ltd., Hologic, Inc., Koninklijke Philips N.V., Samsung Electronics Co., Ltd, Shimadzu Corporation, Siemens Healthineer AG, and Terumo Corporation among others.

Vascular Imaging Market Scope

Buy Now


Premium Report Details

  • Base Year: 2023
  • Companies covered: 10
  • Tables & Figures: 289
  • Countries covered: 22
  • Pages: 210
 Download Free Sample